Pharmafile Logo
Pharmafocus logo
Advanced Search
Bayer image

Bayer and Gilead expand in manufacturing

June 2, 2015
Manufacturing and Production, Sales and Marketing Bayer, Gilead, brett wells, manufacturing

Both Bayer and Gilead are investing heavily into their manufacturing operations with expansion plans being laid down in Indonesia and …

News
Roche logo

NICE signs-off Roche’s Gazyvaro for leukaemia

June 2, 2015
Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia

NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …

News
Mylan image

Mylan tells Teva to ‘stop playing games’ and make firm bid

June 2, 2015
Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics

Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …

News
corinne_le_goff

Amgen hires head of Europe from Roche

June 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche

Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …

Appointment

NICE Lynparza rejection labelled ‘hard to understand’

June 2, 2015
Sales and Marketing AstraZeneca, NICE, lynparza, olaparib

AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …

News
AZ image

AstraZeneca lung drug shines on

June 1, 2015
Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar

AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …

News
yervoy image

BMS immunotherapy combination impresses at ASCO

June 1, 2015
Research and Development, Sales and Marketing ASCO, BMS, Yervoy, opdivo

Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …

News

Pfizer breast cancer drug delivers

June 1, 2015
Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells

A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …

News
paolo_paoletti

Former GSK Oncology president joins Kesios

June 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, kesios

The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …

Appointment
web23andme-emilydrabant

Searching for new biotech solutions

June 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Emily Drabant Conley, google

For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …

Feature
Opdivo

BMS’ Opdivo improves lung cancer survival

May 29, 2015
Research and Development, Sales and Marketing ASCO, BMS, Bristol-Myers Squibb, NSCLC, lung cancer, nivolumab, non-small cell lung cancer, opdivo

A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …

News
novartis_window

NICE green-light for Novartis skin drug

May 29, 2015
Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab

NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …

News
lilly_logo_building

Lilly and AstraZeneca collaborate on cancer trials

May 29, 2015
Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I

AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …

News
Pfizer image

Pfizer gets first approval for rare lung disease

May 29, 2015
Sales and Marketing FDA, Pfizer, Rapamune, lung disease

Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …

News

Teva settles generic ‘pay-to-delay’ case for $1.2 billion

May 29, 2015
Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil

Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …

News
Merkel image

Sanofi plays host to German chancellor Angela Merkel

May 29, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel

German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …

News
screen_shot_2015-05-29_at_07

Huntingdon and Harlan names corporate marketing VP

May 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntingdon and Harlan, joseph bedford

UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …

Appointment
lilly

Two new diabetes drugs approved

May 28, 2015
Sales and Marketing Japan, Takeda, diabetes in China, lilly

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …

News
Eisai image

Eisai seeks new ALS drug approval

May 28, 2015
Sales and Marketing Eisai, Japan, als, mecobalamin

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …

News
valeant_pharma

Actavis and Valeant see FDA approval for IBS drugs

May 28, 2015
Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells

Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026